skip to main content
DOE Patents title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Palladium-109 labeled anti-melanoma monoclonal antibodies

Abstract

Palladium-109, a beta-emitting radionuclide, when chelated to anti-melanoma monoclonal antibody demonstrates high uptake in melanoma and thus is useful for tumor therapy.

Inventors:
 [1];  [2];  [3]
  1. (Setauket, NY)
  2. (Pelham, NY)
  3. (Scarsdale, NY)
Issue Date:
Research Org.:
ASSOC UNIVERSITIES INC
OSTI Identifier:
875259
Patent Number(s):
H819
Assignee:
United States of America as represented by Secretary of Energy (Washington, DC) BNL
DOE Contract Number:  
AC02-76CH00016
Resource Type:
Patent
Country of Publication:
United States
Language:
English
Subject:
palladium-109; labeled; anti-melanoma; monoclonal; antibodies; beta-emitting; radionuclide; chelated; antibody; demonstrates; uptake; melanoma; useful; tumor; therapy; monoclonal antibody; monoclonal antibodies; tumor therapy; emitting radionuclide; anti-melanoma monoclonal; /424/435/436/530/

Citation Formats

Srivastava, Suresh C., Fawwaz, Rashid A., and Ferrone, Soldano. Palladium-109 labeled anti-melanoma monoclonal antibodies. United States: N. p., 1990. Web.
Srivastava, Suresh C., Fawwaz, Rashid A., & Ferrone, Soldano. Palladium-109 labeled anti-melanoma monoclonal antibodies. United States.
Srivastava, Suresh C., Fawwaz, Rashid A., and Ferrone, Soldano. Mon . "Palladium-109 labeled anti-melanoma monoclonal antibodies". United States. https://www.osti.gov/servlets/purl/875259.
@article{osti_875259,
title = {Palladium-109 labeled anti-melanoma monoclonal antibodies},
author = {Srivastava, Suresh C. and Fawwaz, Rashid A. and Ferrone, Soldano},
abstractNote = {Palladium-109, a beta-emitting radionuclide, when chelated to anti-melanoma monoclonal antibody demonstrates high uptake in melanoma and thus is useful for tumor therapy.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {1990},
month = {1}
}

Patent:

Save / Share: